Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample.

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Abstract Text:

Jacqueline F Marcus,Janet S Cellar,Farzaneh Pour Ansari,Donald L Bliwise,Jacqueline F Marcus,Janet S Cellar,Farzaneh Pour Ansari,Donald L Bliwise,

BACKGROUND: Wandering represents a major problem in the management of patients with Alzheimer's disease (AD). In this study we examined the utility of the Algase Wandering Scale (AWS), a newly developed psychometric instrument that asks caregivers to assess the likelihood of wandering behavior. METHODS: The AWS was administered to the caregivers of 40 AD patients and total and subscale scores were examined in relation to measures of mental and functional status, depressive symptoms and medication usage. RESULTS: AWS scores were comparable, though slightly lower, than those normative values previously published. Higher scores were associated with more severe dementia. The Negative Outcome subscale showed a significant increase in reported falls or injuries in association with anti-depressant use. CONCLUSIONS: These data provide some construct validation for the AWS as a potentially useful scale to assess wandering behaviors in AD.

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Publishing Authors By Initials

JF Marcus,JS Cellar,FP Ansari,DL Bliwise,JF Marcus,JS Cellar,FP Ansari,DL Bliwise,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of geriatric psychiatry

VOLUME: 22

Page Numbers: 801-5

Journal Abbreviation:

ISSN: 0885-6230

DAY: 31

MONTH: Aug

YEAR: 2007

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8710629

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample.

AFFILIATION: Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.

Country: England

AGENCY: United States NIA

GRANT: AG025688

ACRONYM: AG

MEDLINETA: Int J Geriatr Psychiatry

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample Related Publications

• Association of sleep difficulty with Kidney Disease Quality of Life cognitive function score reported by patients who recently started dialysis.
• Effects of moderate-intensity exercise on polysomnographic and subjective sleep quality in older adults with mild to moderate sleep complaints.
• Is sleep apnea a cause of reversible dementia in old age?
• Patient-reported sleep difficulty and cognitive function during the first year of dialysis.
• Polysomnographic and clinical correlates of behaviorally observed daytime sleep in nursing home residents.
• Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years.
• Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort.
• Sleep-disordered breathing and nocturia in older adults.
• Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample.